ISCO — International Stem Cell Cashflow Statement
0.000.00%
Last trade - 00:00- $0.88m
- $3.05m
- $9.09m
- 44
- 75
- 56
- 60
Annual cashflow statement for International Stem Cell, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.72 | -0.899 | -0.331 | -0.131 | -0.209 |
| Depreciation | |||||
| Non-Cash Items | 1.51 | 0.163 | 0.672 | 0.766 | 0.825 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.623 | -0.823 | -0.227 | 0.1 | -0.809 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.341 | -1.3 | 0.332 | 0.929 | 0.013 |
| Capital Expenditures | -0.108 | -0.045 | -0.011 | -0.08 | -0.171 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -0.003 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.108 | -0.045 | -0.011 | -0.083 | -0.171 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.654 | 0.824 | 0.25 | 0 | -0.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.205 | -0.518 | 0.571 | 0.846 | -0.358 |